Migraine Minute News Update  By  cover art

Migraine Minute News Update

By: Association of Migraine Disorders
  • Summary

  • The Migraine Minute provides weekly updates in migraine research and news hosted by Molly O'Brien of the Association of Migraine Disorders.
    Show more Show less
Episodes
  • Can This Gepant be an Effective Preventive Treatment Option for Tough to Treat Episodic Migraine?
    May 31 2024

    A study in the Lancet found one oral gepant to be safe and effective in people with episodic migraine who have failed two to four classes of preventive treatments. Molly O’Brien explains in this Migraine Minute News Update. Read the study here: https://bit.ly/3w3ZM45

    Show more Show less
    1 min
  • Comparing Anti-CGRP monoclonal antibodies to OnabotulinumtoxinA for chronic migraine
    May 17 2024

    A new study looks at real-word effectiveness of Anti-CGRP monoclonal antibodies & OnabotulinumtoxinA for chronic migraine. Molly O'Brien will share the study findings in this Migraine Minute News update. Read the study: https://bit.ly/4d1mPx1


    *The graphic used in this content is courtesy of Grazzi, L., Giossi, R., Montisano, D.A. et al. Real-world effectiveness of Anti-CGRP monoclonal antibodies compared to OnabotulinumtoxinA (RAMO) in chronic migraine: a retrospective, observational, multicenter, cohort study. J Headache Pain 25, 14 (2024). https://doi.org/10.1186/s10194-024-01721-6. The graphical abstract has been slightly modified.

    Show more Show less
    1 min
  • Can blood flow changes in the eyes explain visual migraine symptoms?
    May 3 2024

    Researchers at the University of California Los Angeles found changes in blood flow in the retina might explain why some people have visual migraine symptoms. Molly O'Brien has the details in this Migraine Minute News update.

    Learn more: https://bit.ly/3xou7uw , https://bit.ly/4aErYZN

    Show more Show less
    1 min

What listeners say about Migraine Minute News Update

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.